Table 1.
Summary of Patients’ Characteristics
| Patient | Sex | Age | AD of Duration (Years) | Visible Areas | Comorbidities | EASI (W0/8/16) | BSA%(W0/8/16) | Serum IgE (IU/L) | Patch Test | Adverse Event |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 67 | 1 | Face, Hands, Torso, Leg | - | 37.4/22.6/16.7 | 23/18/10 | 1004 | - | - |
| 2 | M | 29 | 3 | Face, Hands, Torso | - | 23.8/15.7/11.7 | 18/13/9 | - | - | Head and Neck Dermatitis |
| 3 | F | 40 | 5 | Face, Hands, Torso, Leg | AR | 13.2/9.6/5.3 | 12/10/6 | - | - | - |
| 4 | M | 15 | 14 | Face, Hands, Torso, Leg | AR | 14.8/7.2/5.1 | 12/6/5 | >2000 | - | - |
| 5 | M | 11 | 4 | Face, Torso, Leg | - | 22.5/16.3/9.8 | 19/13/6 | - | + | - |
| 6 | M | 7 | 5 | Face, Torso, Leg | - | 18.3/12.6/4 | 15/9/5 | 436 | - | |
| 7 | M | 5 | 5 | Face, Hands, Torso, Leg | AR | 38.7/22.4/13.7 | 22/14/7 | >2000 | + | - |
| 8 | M | 7 | 5 | Face, Hands, Torso, Leg | AS, AR | 16.6/10.7/4.3 | 13/7/5 | 855 | - | - |
| 9 | M | 9 | 6 | Face, Hands, Torso, Leg | AK | 19/13.5/4.8 | 21/11/7 | 797 | - | - |
| 10 | F | 8 | 7 | Face, Torso | - | 16.8/12.4/9.8 | 12/7/6 | - | - | - |
Abbreviations: M, male; F, female; AR, allergic rhinitis; AK, allergic keratoconjunctivitis; AS, asthma; T0, baseline; T4, 16 weeks after induction; IGA, investigator’s global assessment; EASI, eczema area, and severity index score;-, none.